220 related articles for article (PubMed ID: 18788623)
1. [Target volume definition, verification and correction in image-guided conformal intensity-modulated radiotherapy for non-small cell lung cancer].
Zhang YJ; Li JB; Yu JM
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):241-4. PubMed ID: 18788623
[No Abstract] [Full Text] [Related]
2. [Advances in image-guided intensity modulated conformal radiotherapy of non-small cell lung cancer].
Xing J; Li JB; Yu JM
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):401-4. PubMed ID: 17974269
[No Abstract] [Full Text] [Related]
3. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.
Christian JA; Bedford JL; Webb S; Brada M
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):735-41. PubMed ID: 17187941
[TBL] [Abstract][Full Text] [Related]
4. Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study.
Lavrenkov K; Singh S; Christian JA; Partridge M; Nioutsikou E; Cook G; Bedford JL; Brada M
Radiother Oncol; 2009 Jun; 91(3):349-52. PubMed ID: 18995919
[TBL] [Abstract][Full Text] [Related]
5. The role of PET in target localization for radiotherapy treatment planning.
Rembielak A; Price P
Onkologie; 2008 Feb; 31(1-2):57-62. PubMed ID: 18268401
[TBL] [Abstract][Full Text] [Related]
6. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
Elsayad K; Kriz J; Reinartz G; Scobioala S; Ernst I; Haverkamp U; Eich HT
Strahlenther Onkol; 2016 Feb; 192(2):83-91. PubMed ID: 26630946
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography.
Harsolia A; Hugo GD; Kestin LL; Grills IS; Yan D
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):582-9. PubMed ID: 18207034
[TBL] [Abstract][Full Text] [Related]
8. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
Gong HY; Yu JM; Fu Z; Li BS; Li JB; Liu TH
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
[TBL] [Abstract][Full Text] [Related]
9. Intensity-modulated radiotherapy, not 3 dimensional conformal, is the preferred technique for treating locally advanced lung cancer.
Chang JY
Semin Radiat Oncol; 2015 Apr; 25(2):110-6. PubMed ID: 25771415
[TBL] [Abstract][Full Text] [Related]
10. Photons or protons: precision radiotherapy of lung cancer.
Auberger T; Seydl K; Futschek T; Sztankay A; Sweeney RA; Lukas P
Strahlenther Onkol; 2007 Dec; 183 Spec No 2():3-6. PubMed ID: 18166995
[No Abstract] [Full Text] [Related]
11. [Advances in research on biological target volume and conformal intensity-modulated radiotherapy].
Yu JM; Chen SQ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):801-3. PubMed ID: 17415998
[No Abstract] [Full Text] [Related]
12. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases.
Yartsev S; Chen J; Yu E; Kron T; Rodrigues G; Coad T; Trenka K; Wong E; Bauman G; Dyk JV
Radiother Oncol; 2006 Feb; 78(2):169-76. PubMed ID: 16413621
[TBL] [Abstract][Full Text] [Related]
13. Defining target volumes for non-small cell lung carcinoma.
Senan S; Chapet O; Lagerwaard FJ; Ten Haken RK
Semin Radiat Oncol; 2004 Oct; 14(4):308-14. PubMed ID: 15558505
[TBL] [Abstract][Full Text] [Related]
14. EPID-based in vivo dosimetry for stereotactic body radiotherapy of non-small cell lung tumors: Initial clinical experience.
Consorti R; Fidanzio A; Brainovich V; Mangiacotti F; De Spirito M; Mirri MA; Petrucci A
Phys Med; 2017 Oct; 42():157-161. PubMed ID: 29173910
[TBL] [Abstract][Full Text] [Related]
15. Inversed-Planned Respiratory Phase Gating in Lung Conformal Radiation Therapy.
Modiri A; Sabouri P; Gu X; Timmerman R; Sawant A
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):317-324. PubMed ID: 28871981
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric evaluation of inspiration and expiration breath-hold for intensity-modulated radiotherapy planning of non-small cell lung cancer.
Tahir BA; Bragg CM; Lawless SE; Hatton MQ; Ireland RH
Phys Med Biol; 2010 Apr; 55(8):N191-9. PubMed ID: 20348604
[TBL] [Abstract][Full Text] [Related]
17. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
[TBL] [Abstract][Full Text] [Related]
18. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
19. A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer.
Munck af Rosenschöld P; Aznar MC; Nygaard DE; Persson GF; Korreman SS; Engelholm SA; Nyström H
Acta Oncol; 2010 Oct; 49(7):1141-8. PubMed ID: 20831506
[TBL] [Abstract][Full Text] [Related]
20. A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.
Lavrenkov K; Christian JA; Partridge M; Niotsikou E; Cook G; Parker M; Bedford JL; Brada M
Radiother Oncol; 2007 May; 83(2):156-62. PubMed ID: 17493699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
